BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 281551)

  • 41. Mammary cancer stages in BALB/cV mice: mouse mammary tumor virus expression and virus-host interactions.
    Slagle BL; Medina D; Butel JS
    J Natl Cancer Inst; 1987 Aug; 79(2):323-35. PubMed ID: 3037152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of the proliferative response to lysophosphatidic acid in primary cultures of mammary epithelium: differences between normal and tumor cells.
    Imagawa W; Bandyopadhyay GK; Nandi S
    Exp Cell Res; 1995 Jan; 216(1):178-86. PubMed ID: 7813618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transformed growth phenotype of mouse mammary epithelium in primary culture induced by specific fetal mesenchymes.
    Kanazawa T; Hosick HL
    J Cell Physiol; 1992 Nov; 153(2):381-91. PubMed ID: 1429857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth regulation of mouse mammary tumor cells in collagen gel cultures by diffusible factors produced by normal mammary gland epithelium and stromal fibroblasts.
    Miller FR; McEachern D; Miller BE
    Cancer Res; 1989 Nov; 49(21):6091-7. PubMed ID: 2790822
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nononcogenic hormone-independent alveoli produced by carcinogens in cultured mouse mammary glands.
    Schaefer FV; Tonelli QJ; Dickens MS; Custer RP; Sorof S
    Cancer Res; 1983 Jul; 43(7):3310-5. PubMed ID: 6406057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. p53 mutations in mouse mammary epithelial cells: instability in culture and discordant selection of mutations in vitro versus in vivo.
    Ozbun MA; Medina D; Butel JS
    Cell Growth Differ; 1993 Oct; 4(10):811-9. PubMed ID: 8274450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epithelial component of host-tumor interactions in the orthotopic site preference of a mouse mammary tumor.
    Miller FR; McInerney D
    Cancer Res; 1988 Jul; 48(13):3698-701. PubMed ID: 3378213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and characterization of mouse hyperplastic mammary outgrowth lines from BALB/cfC3H hyperplastic alveolar nodules.
    Ashley RL; Cardiff RD; Mitchell DJ; Faulkin LJ; Lund JK
    Cancer Res; 1980 Nov; 40(11):4232-42. PubMed ID: 6258774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of epidermoid differentiation by cyclic adenine nucleotide in cultured mammary tumors of mice.
    Schaefer FV; Custer RP; Sorof S
    Cancer Res; 1985 Apr; 45(4):1828-33. PubMed ID: 2983888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
    Vaillant F; Asselin-Labat ML; Shackleton M; Forrest NC; Lindeman GJ; Visvader JE
    Cancer Res; 2008 Oct; 68(19):7711-7. PubMed ID: 18829523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth and differentiation of hyperplastic outgrowths derived from mouse mammary epithelial cells transformed in organ culture.
    Ganguly N; Ganguly R; Mehta NM; Banerjee MR
    J Natl Cancer Inst; 1982 Aug; 69(2):453-63. PubMed ID: 6810005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characteristics of normal rat mammary epithelial cells and N-ethyl-N-nitrosourea-induced mammary adenocarcinoma cells grown in culture.
    Stoica G; Koestner A; O'Leary M
    Anticancer Res; 1985; 5(5):499-509. PubMed ID: 2415045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MMTV-EGF receptor transgene promotes preneoplastic conversion of multiple steroid hormone-responsive tissues.
    Marozkina NV; Stiefel SM; Frierson HF; Parsons SJ
    J Cell Biochem; 2008 Apr; 103(6):2010-8. PubMed ID: 17960555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effects of selenium on the growth of mouse mammary cells in vitro.
    Medina D; Oborn CJ
    Cancer Lett; 1981 Sep; 13(4):333-44. PubMed ID: 7306960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancement of the tumorigenicity of preneoplastic mammary nodule lines by enzymatic dissociation.
    Medina D; Shepherd F; Gropp T
    J Natl Cancer Inst; 1978 May; 60(5):1121-6. PubMed ID: 205661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A critical role for the inflammatory response in a mouse model of preneoplastic progression.
    Schwertfeger KL; Xian W; Kaplan AM; Burnett SH; Cohen DA; Rosen JM
    Cancer Res; 2006 Jun; 66(11):5676-85. PubMed ID: 16740705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional markers and growth behavior of preneoplastic hepatocytes.
    Williams GM
    Cancer Res; 1976 Jul; 36(7 PT 2):2540-3. PubMed ID: 58721
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased agglutinability and haemadsorption of Marek's disease HPRS line 1 lymphoblastoic cells after concanavalin A treatment.
    Benda V; Branny J
    Folia Biol (Praha); 1979; 25(5):288-92. PubMed ID: 231521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic cooperation in vitro: differential ability of ouabain to uncouple normal, preneoplastic, and neoplastic mouse mammary cells.
    Miller FR; McInerney D; Miller BE
    Biochem Biophys Res Commun; 1986 Nov; 140(3):955-61. PubMed ID: 3778494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.